Evotec (NASDAQ:EVO) Shares Gap Down – Here’s Why

Evotec SE (NASDAQ:EVO)’s share price gapped down before the market opened on Thursday . The stock had previously closed at $3.41, but opened at $3.29. Evotec shares last traded at $3.29, with a volume of 4,840 shares changing hands.

Evotec Stock Down 0.3 %

The business has a fifty day moving average of $4.07 and a 200 day moving average of $4.10. The company has a quick ratio of 1.99, a current ratio of 2.09 and a debt-to-equity ratio of 0.43.

Institutional Trading of Evotec

Institutional investors have recently added to or reduced their stakes in the business. Wellington Management Group LLP boosted its position in Evotec by 29.7% during the 3rd quarter. Wellington Management Group LLP now owns 2,634,434 shares of the company’s stock valued at $9,616,000 after purchasing an additional 602,858 shares during the period. Lighthouse Investment Partners LLC acquired a new stake in shares of Evotec in the fourth quarter valued at approximately $166,000. DCF Advisers LLC boosted its position in Evotec by 5.9% during the 4th quarter. DCF Advisers LLC now owns 229,871 shares of the company’s stock worth $956,000 after acquiring an additional 12,816 shares during the period. CSS LLC IL acquired a new position in shares of Evotec during the fourth quarter valued at $50,000. Finally, Bank of America Corp DE raised its stake in shares of Evotec by 262.5% during the fourth quarter. Bank of America Corp DE now owns 12,828 shares of the company’s stock valued at $53,000 after purchasing an additional 9,289 shares in the last quarter. Institutional investors own 5.81% of the company’s stock.

About Evotec

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women’s health.